RELATING TO HEALTH.

Requires Medicaid and private insurance coverage for intravenous ketamine therapy to treat depression. Appropriates moneys.

Voted 2/6/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

2/6/2026The committee on HHS deferred the measure.
2/3/2026The committee(s) on HHS has scheduled a public hearing on 02-06-26 1:00PM; Conference Room 225 & Videoconference.
12/8/2025Carried over to 2026 Regular Session.
1/23/2025Referred to HHS, CPN/WAM.
1/21/2025Passed First Reading.
1/17/2025Introduced.